StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

Research analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research note issued to investors on Thursday. The firm set a “hold” rating on the stock.

China Pharma Stock Down 18.8 %

Shares of NYSE CPHI opened at $0.21 on Thursday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. The stock’s 50-day simple moving average is $0.21 and its two-hundred day simple moving average is $0.22. China Pharma has a twelve month low of $0.13 and a twelve month high of $0.60.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.